iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding iSpecimen Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 417.6K | 385.2K | −32.4K (−7.8%) |
| Value | $596.9K | $238.5K | −$358.3K (−60.0%) |
New holders (4)
Institutions that held iSpecimen Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 22,770 | $14.1K | 0.00% |
| HRT Financial LP | 13,380 | $8.00K | 0.00% |
| UBS Group AG | 104 | $64 | 0.00% |
| JPMorgan Chase & Co | 5 | $3 | 0.00% |
Sold out (4)
Institutions that held iSpecimen Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Citadel Advisors LLC | 23,173 | $33.1K |
| Claro Advisors LLC | 17,305 | $24.7K |
| Renaissance Technologies LLC | 14,904 | $21.0K |
| Morgan Stanley | 8,000 | $11.4K |